Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.15−0.07 (-0.97%)
Close on Nov 17, 2026Market cap $741.49MP/E –Yield –
Aura Biosciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aura Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$138.08M. For fiscal 2025 it was -$112.79M. The highest annual figure on record is -$22.21M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$112.79M | – |
| FY2024 | Dec 31, 2024 | -$96.12M | – |
| FY2023 | Dec 31, 2023 | -$84.99M | – |
| FY2022 | Dec 31, 2022 | -$60.30M | – |
| FY2021 | Dec 31, 2021 | -$35.25M | – |
| FY2020 | Dec 31, 2020 | -$22.21M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$48.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$34.87M | – |
| Q4 FY2025 | Dec 31, 2025 | -$27.24M | – |
| Q3 FY2025 | Sep 30, 2025 | -$27.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$28.61M | – |
| Q1 FY2025 | Mar 31, 2025 | -$29.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$27.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.76M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.44M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.61M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.63M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.90M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.80M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.93M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.91M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.63M | – |
See a number that looks wrong?